The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
Abstract
Decreased low-density lipoprotein (LDL) particle size is associated with coronary heart disease (CHD) risk among middle-aged Caucasian populations, and has been consistently correlated with increased plasma levels of triglyceride and decreased levels of high-density lipoprotein (HDL) cholesterol. This study examines whether these risk factors predict CHD among older Japanese-American men. With use of the Honolulu Heart Program Lipoprotein Exam 3 (1980 to 1982) as baseline, and 12-year follow-up for CHD events, a nested, case-control study was designed. One hundred forty-five incident CHD cases were identified and matched to 2 controls each. LDL particle diameter (size) was determined by gradient gel electrophoresis. A 10-angstrom (A) decrease in LDL size at baseline was associated with increased risk of incident CHD (relative risk 1.28, 95% confidence interval 1.01 to 1.63). After adjustment for baseline risk factors, the LDL size association was no longer statistically significant (relative risk 1.13, 95% confidence interval 0.86 to 1.49). When principal components analysis was used to define a composite variable for LDL size, triglycerides, and HDL cholesterol, this component predicted CHD independent of smoking, alcohol consumption, physical activity, body mass index, hypertension, diabetes, and beta-blocker use (p <0.01). Therefore, this prospective analysis of data from older, Japanese-American men demonstrated that decreased LDL size is a univariate predictor of incident CHD, and that a composite risk factor of LDL size, triglyceride, and HDL cholesterol was a risk factor for CHD independent of other risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A high small dense LDL level is a risk factor for ASCVD. (Evidence level: E-1a)”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [254]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,652
Applied Regression Analysis and Other Multivariable Methods
Walker, E., Kleinbaum, D. G., Kupper, L. L., & Muller, K. E. (1989) · Technometrics · doi:10.2307/1270375 · Cited by 8,538
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Self-citationHokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Self-citationApplied Multivariate Statistics for the Social Sciences
Schumm, W. R., & Stevens, J. P. (1993) · The American Statistician · doi:10.2307/2685203 · Cited by 1,533
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Self-citationThe design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,081
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Research works printed but not linked: 1
- Austin, 1999, LDL particle size is a risk factor for coronary heart disease independent of triglyceride and HDL cholesterol, Circulation, 99, 1124
Cited by
Sorted by citations
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 637
Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 465
St-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Circulation · doi:10.1161/01.cir.0000145615.33955.83 · Cited by 358
Lipoprotein (a) measurements for clinical application
Marcovina, S. M., & Albers, J. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061648 · Cited by 338
Kuller, L. H., Arnold, A. M., Tracy, R. P., Otvos, J. D., Burke, G. L., Psaty, B. M., Siscovick, D. S., Freedman, D. S., & Kronmal, R. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022015.97341.3a · Cited by 310
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., SHALAUROVA, I. Y., Cupples, L. A., Parise, H., D’Agostino, R. B., Wilson, P. W. F., & Schaefer, E. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032763 · Cited by 304
Low-density lipoprotein size and cardiovascular risk assessment
Rizzo, M., & Berneis, K. K. (2005) · QJM · doi:10.1093/qjmed/hci154 · Cited by 259
St-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., Bernard, P., Després, J., & Lamarche, B. (2001) · Circulation · doi:10.1161/hc4401.098490 · Cited by 259
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
Sacks, F. M., & Campos, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030636 · Cited by 241
Low-density lipoprotein particle number and risk for cardiovascular disease
Cromwell, W. C., & Otvos, J. D. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0050-5 · Cited by 198
Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.
Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-7-200904070-00007 · Cited by 163
Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Digestive Diseases · doi:10.1159/000282087 · Cited by 130
Dietary and Genetic Probes of Atherogenic Dyslipidemia
Krauss, R. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186365.73973.f0 · Cited by 124
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
Sniderman, A. D., Couture, P., & Graaf, J. D. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.50 · Cited by 118
Parish, S., Peto, R., Palmer, A. J., Clarke, R. T., Lewington, S., Offer, A. R., Whitlock, G., Clark, S., Youngman, L. D., Sleight, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp221 · Cited by 121
Effects of extended-release niacin on lipoprotein subclass distribution
Morgan, J. M., Capuzzi, D. M., Baksh, R. I., INTENZO, C. M., Carey, C. M., Reese, D., & Walker, K. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00394-1 · Cited by 111
Comparative effects of lipid-lowering therapies
Davidson, M. H., & Toth, P. P. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.007 · Cited by 106
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
Gazi, I. F., Tsimihodimos, V., Tselepis, A. D., Elisaf, M., & Mikhailidis, D. P. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.53 · Cited by 98
Is it LDL particle size or number that correlates with risk for cardiovascular disease?
Superko, H. R., & Gadesam, R. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0059-2 · Cited by 91
Biavatti, M. W., Farias, C., Curtius, F., Brasil, L. M., Hort, S., Schuster, L., Leite, S. N., & Prado, S. R. T. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.04.015 · Cited by 91
Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?
Imke, C., Rodríguez, B. L., Grove, J., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B. J., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 89
Self-citationSwiger, K. J., Martin, S. S., Blaha, M. J., Toth, P. P., Nasir, K., Michos, E. D., Gerstenblith, G., Blumenthal, R. S., & Jones, S. R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000851 · Cited by 77
Klafke, J. Z., da Silva, M. A., Panigas, T. F., Belli, K. C., de Oliveira, M. F., Barichello, M. M., Rigo, F. K., Rossato, M. F., Santos, A. R. S., Pizzolatti, M. G., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.11.004 · Cited by 68
Viecili, P. R. N., Borges, D. O., Kirsten, K., Malheiros, J., Viecili, E., Melo, R. D., Trevisan, G., da Silva, M. A., Bochi, G. V., Moresco, R. N., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.010 · Cited by 65
Arsenault, B. J., Lemieux, I., Despres, J.-P., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., & Boekholdt, S. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm390 · Cited by 63
Vakkilainen, J., Jauhiainen, M., Ylitalo, K., Nuotio, I. O., Viikari, J. S. A., Ehnholm, C., & Taskinen, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31489-9 · Cited by 63
Kang, H.-S., Gutin, B., Barbeau, P., Litaker, M., Allison, J., & Le, N. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802045 · Cited by 61
Gómez-Marcos, M. Á., Blázquez‐Medela, A. M., Gamella-Pozuelo, L., Recio-Rodriguez, J. I., García‐Ortiz, L., & Martínez‐Salgado, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9124676 · Cited by 63
Chirovsky, D. R., Fedirko, V., Cui, Y. A., Sazonov, V., & Barter, P. J. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832c8891 · Cited by 58
Low Density Lipoprotein Particle Size and Risk of Early-Onset Myocardial Infarction in Women
Kamigaki, A. S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.10.939 · Cited by 59
Wong, N. D. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00004 · Cited by 55
Park, I., Paeng, K., Yoon, Y., Song, J.-H., & Moon, M. H. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00630-x · Cited by 53
Sniderman, A. D., & Marcovina, S. M. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.007 · Cited by 49
Polycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 49
Toft‐Petersen, A. P., Tilsted, H. H., Aarøe, J., Rasmussen, K., Christensen, T., Griffin, B. A., Aardestrup, I. V., Andreasen, A., & Schmidt, E. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-21 · Cited by 47
Low‐density‐lipoprotein peak particle size in a Mediterranean population
Rizzo, M., Barbagallo, C. M., Severino, M., Polizzi, F., Onorato, F., Noto, D., Cefalu, A. B., Pace, A., Marino, G., Notarbartolo, A., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01125.x · Cited by 43
Polyacrylamide Gradient Gel Electrophoresis of Lipoprotein Subclasses
Warnick, G. R., McNamara, J. R., Boggess, C. N., Clendenen, F., Williams, P. T., & Landolt, C. C. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.005 · Cited by 42
Forti, N. A., & Diament, J. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001800019 · Cited by 43
Lee, J. Y., Min, H. K., Choi, D., & Moon, M. H. (2010) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.01.006 · Cited by 38
Sirtori, C. R., Calabresi, L., Pisciotta, L., Cattin, L., Pauciullo, P., Montagnani, M., Manzato, E., Bon, G. B., & Fellin, R. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2004.08.001 · Cited by 37
Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension
Felmeden, D. C., Spencer, C. G. C., Blann, A. D., Beevers, D. G., & Lip, G. Y. H. (2003) · Hypertension · doi:10.1161/01.hyp.0000056997.40992.41 · Cited by 36
Austin, M. A., Edwards, K. L., Monks, S. A., Koprowicz, K. M., Brunzell, J. D., Motulsky, A. G., Mahaney, M. C., & Hixson, J. E. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300272-jlr200 · Cited by 35
Self-citationPREVALENCE OF METABOLIC SYNDROME AMONG MIDDLE AGED WOMEN IN BABOL, IRAN
Hanachi, P. (2005) · PubMed · doi:10.5281/zenodo.2665350 · Cited by 35
Froyen, E. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01501-0 · Cited by 38
Lee, J. Y., Byeon, S. K., & Moon, M. H. (2014) · Analytical Chemistry · doi:10.1021/ac503973p · Cited by 31
Ho, R. C., Davy, K. P., Davy, B. M., & Melby, C. L. (2002) · Metabolism · doi:10.1053/meta.2002.35577 · Cited by 30
Bria, C. R. M., Afshinnia, F., Skelly, P. W., Rajendiran, T. M., Kayampilly, P. P., Thomas, T. P., Andreev, V. P., Pennathur, S., & Williams, S. K. R. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1499-3 · Cited by 28
Zappi, A., Marassi, V., Giordani, S., Kassouf, N., Roda, B., Zattoni, A., Reschiglian, P., & Melucci, D. (2023) · Chemosensors · doi:10.3390/chemosensors11010045 · Cited by 28
Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke
Zhao, C. X., Cui, Y., Fan, Q., Wang, P. H., Hui, R.-T., Cianflone, K., & Wang, D. W. (2008) · Cerebrovascular Diseases · doi:10.1159/000175768 · Cited by 28
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
Toth, P. P. (2001) · Disease-a-Month · doi:10.1067/mda.2001.118859 · Cited by 28
Tada, H., Kawashiri, M., Nomura, A., Yoshimura, K., Itoh, H., Komuro, I., & Yamagishi, M. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318796989 · Cited by 27
Fenofibric acid for hyperlipidemia
Saurav, A., Kaushik, M., & Mohiuddin, S. M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.658774 · Cited by 28
Jug, B., Papazian, J., Lee, R., & Budoff, M. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.016 · Cited by 26
Antioxidant enzymes in hypertensive and hypertriglyceridemic rats: Effect of gender
Baños, G., Medina-Campos, O. N., Maldonado, P. D., Zamora, J., Pérez, I., Pavón, N., & Pedraza-Chaverrí, J. (2005) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200044255 · Cited by 25
Field-Flow Fractionation in Molecular Biology and Biotechnology
Giordani, S., Marassi, V., Placci, A., Zattoni, A., Roda, B., & Reschiglian, P. (2023) · Molecules · doi:10.3390/molecules28176201 · Cited by 24
Porphyromonas gingivalis–dendritic cell interactions: consequences for coronary artery disease
Zeituni, A. E., Carrion, J. A., & Cutler, C. W. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5782 · Cited by 26
Regulation of small dense LDL concentration in Korean and Scottish men and women
Cho, H. K., Shin, G.-J., Ryu, S. K., Jang, Y., Day, S., Stewart, G., Packard, C. J., Shepherd, J., & CASLAKE, M. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00058-8 · Cited by 25
Insulin Resistance in Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch11 · Cited by 27
Atherogenic dyslipidemia in patients with established coronary artery disease
Lahoz, C., Mostaza, J. M., Tranche, S., Martı́n-Jadraque, R., Mantilla, M. T., López-Rodríguez, I., Monteiro, B., Sanchez-Zamorano, M., & Taboada, M. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.04.010 · Cited by 23
Therapeutic interventions targeted at the augmentation of reverse cholesterol transport
Toth, P. P., & Davidson, M. H. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000126583.35391.eb · Cited by 23
Treatment of Hyperlipidemia from Japanese Evidence
Koba, S., & Sasaki, J. D. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.267 · Cited by 22
Physical activity, diet and cardiovascular disease risks in Chinese women
Ma, J., Liu, Z., & Ling, W. (2003) · Public Health Nutrition · doi:10.1079/phn2002393 · Cited by 22
Relationships Among Health Behaviors, Health, and Mortality
Himes, C. L. (2011) · International handbooks of population · doi:10.1007/978-90-481-9996-9_14 · Cited by 23
Yang, I. S., Kim, K. H., Lee, J. Y., & Moon, M. H. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.11.035 · Cited by 20
Polyphenols Present in Campomanesia Genus: Pharmacological and Nutraceutical Approach
Lescano, C. H., de Lima, F. F., Caires, A. R. L., & de Oliveira, I. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813768-0.00027-x · Cited by 20
Miyazaki, Y., Koyama, H., 野尻, 雅., & Suzuki, S. (2002) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/s0946-672x(02)80033-5 · Cited by 20
Corsetti, J. R. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.027 · Cited by 19
Tada, H., Kawashiri, M., & Yamagishi, M. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2016.159 · Cited by 17
Tsai, M. Y., Li, N., Sharrett, A. R., Shea, S., Jacobs, D. R., Tracy, R. P., Arnett, D. K., Arends, V. L., & Post, W. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.107995 · Cited by 18
Kim, K. H., Lee, J. Y., Lim, S., & Moon, M. H. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.01.025 · Cited by 18
Pathophysiology of type 2 diabetes mellitus
Yki‐Järvinen, H. (2011) · doi:10.1093/med/9780199235292.003.1336 · Cited by 22
Prothrombotic markers in asymptomatic dyslipidemic subjects
Karásek, D., Vaverková, H., Halenka, M., Jackuliaková, D., Fryšák, Z., Slavík, L., & Novotný, D. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0474-4 · Cited by 17
Cardiovascular Disease Risk Factors Other than Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17368 · Cited by 16
Schima, S. M., Maciejewski, S. R., Hilleman, D. E., Williams, M. A., & Mohiuddin, S. M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903575639 · Cited by 15
Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation.
Sharma, S. B., & Garg, S. (2012) · PubMed · Cited by 15
Bos, G., Poortvliet, M. C., Scheffer, P. G., Dekker, J. M., Ocké, M. C., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Teerlink, T., & Heine, R. J. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602492 · Cited by 15
Boutari, C., Stefanakis, K., Simati, S., Guatibonza-García, V., Valenzuela‐Vallejo, L., Anastasiou, I. A., Connelly, M. A., Kokkinos, A. D., & Mantzoros, C. S. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02264-5 · Cited by 14
Statin use in the metabolic syndrome
Lundbye, J., & Thompson, P. D. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0070-9 · Cited by 15
Czerwinski, S. A., Mahaney, M. C., Rainwater, D. L., VandeBerg, J. L., MacCluer, J. W., D, M. P. S. M., & Blangero, J. (2004) · Human Biology · doi:10.1353/hub.2005.0014 · Cited by 13
Lee, J. Y., Choi, D., Johan, C., & Moon, M. H. (2010) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.11.079 · Cited by 12
Lipid abnormalities and cardiovascular risk in the elderly
Milionis, H. J., Elisaf, M., & Mikhailidis, D. P. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x273363 · Cited by 11
Ko, Y. C., Huang, M., Wang, T., Chang, S., Tsai, L. Y., & Tu, H. (2005) · Public Health · doi:10.1016/j.puhe.2004.08.013 · Cited by 9
Huang, M., Wang, T., Wang, H.-S., Sung, Y., Ko, Y., & Chiang, H. (2008) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(08)70114-1 · Cited by 9
Cardiovascular health and the menopause: the gynecologist as the patients' interface
Arias, R. D. (2006) · Climacteric · doi:10.1080/13697130600916148 · Cited by 9
Giordani, S., Kassouf, N., Zappi, A., Zattoni, A., Roda, B., Melucci, D., & Marassi, V. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.138206 · Cited by 8
Aziz, K. M. A. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 9
Manurung, D. (2006) · PubMed · Cited by 8
Wang, J., Shen, X., He, S., An, Y., Gong, Q., Li, H., Zhang, B., Shuai, Y., Chen, Y., Hu, Y., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3163 · Cited by 8
Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment
Vaverková, H., Frohlich, J. J., Jackuliaková, D., & Novotný, D. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.02.012 · Cited by 8
Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection
Huang, Y.-J., Cheng, T., Wang, Y., Chen, C., Leu, Y.-L., Chang, C., Ho, C.-H., Chao, S.-W., Li, C.-T., & Chuang, C.-H. (2024) · Journal of Virology · doi:10.1128/jvi.01258-23 · Cited by 7
Lee, H.-S., Jung, C. H., Kim, S. R., Jang, H. C., Park, C., & PROPIT Study Team (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.120 · Cited by 7
Assessing risk using different cholesterol-screening methods
Bowden, R. G., Kingery, P. M., & Rust, D. M. (2003) · Public Health · doi:10.1016/j.puhe.2003.07.001 · Cited by 7
Kim, O. Y., Chung, H. K., & Shin, M. (2012) · Nutrition Research and Practice · doi:10.4162/nrp.2012.6.2.120 · Cited by 6
Metadata
- Authors
- Austin, M. A., Rodriguez, B. L., McKnight, B., McNeely, M. J., Edwards, K. L., Curb, J. D., & Sharp, D. S.
- Affiliations
- University of Washington (US)
- University of Hawaiʻi at Mānoa (US)
- National Institutes of Health (US)
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 86
- Issue
- 4
- Pages
- 412-416
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W1975051427
- Cited by
- 129
- References
- 31
- Citations by year
- 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl050268-09)
- National Heart, Lung, and Blood Institute (R01 HL50268)
- National Cancer Institute (R01CA149051)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- triglycerides, HDL cholesterol, coronary artery disease, cardiovascular risk factors, Japanese-American men, older men, Honolulu Heart Program, incident coronary heart disease, lipoprotein metabolism
- MeSH terms
- Aged, Asian, Coronary Disease, Hawaii, Humans, Japan, Cholesterol, HDL, Lipoproteins, LDL, Male, Middle Aged, Particle Size, Prospective Studies, Risk Factors, Smoking, Triglycerides, Logistic Models, Case-Control Studies, Electrophoresis, Gel, Pulsed-Field
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review